# Rejuvesol

NDC: 23731-7000
Generic name: Sodium Pyruvate, Inosine, Adenine, Sodium Phosphate, Dibasic, and Sodium Phosphate, Monobasic, Monohydrate
Labeler / Manufacturer: Citra Labs, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: EXTRACORPOREAL
Marketing started: 19970226

FDA application: BN950522

## Active ingredients

- ADENINE: .034 g/50mL
- INOSINE: 1.34 g/50mL
- SODIUM PHOSPHATE, DIBASIC: .73 g/50mL
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE: .311 g/50mL
- SODIUM PYRUVATE: .55 g/50mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"23731-7000"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=23731-7000
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc06c40f-81a0-45e5-80b6-61f67d445068